文献速递临床试验与 GCP基础与转化研究

θ爆发式磁刺激作为减少寻求治疗酒精使用者饮酒的工具:一项随机双盲假对照临床试验的研究方案

Theta Burst Stimulation as a tool to decrease drinking in treatment-seeking alcohol users: study protocol for a randomized, double-blind, sham-controlled clinical trial.
PubMed 文献 · Trials · 2025-11-10

本研究为随机双盲假对照临床试验,计划纳入180名酒精使用障碍(AUD)患者,随机接受针对内侧前额叶皮层(MPFC)或背外侧前额叶皮层(DLPFC)的间歇性θ爆发式刺激(iTBS)或假刺激,共30次治疗,并在治疗前后进行MRI扫描及3个月随访,旨在评估iTBS对减少饮酒量、酒精渴求及大脑对酒精线索反应性的疗效。

要点

  • 该试验直接比较MPFC与DLPFC两个iTBS靶点与假刺激对AUD的疗效。
  • 干预为30次iTBS治疗,在3至6周内分15个每日场次完成。
  • 主要评估饮酒量、酒精渴求及大脑对酒精线索的反应性。

核心结论

  • 该试验通过评估两个皮层靶点并采用严谨方法,旨在为优化AUD的TMS治疗提供见解,并支持制定标准化TMS方案及推动FDA批准。

研究设计与样本

  • 随机、双盲、假对照临床试验,计划纳入180名酒精使用障碍个体,随机分为MPFC真iTBS组、DLPFC真iTBS组或假iTBS组。

主要发现

  • 原文未报告结果,因为该文为研究方案。

关键数值与推荐

  • 参与者将完成30次治疗,在3至6周内分15个每日场次进行,并在治疗前后进行MRI扫描及3个月随访。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alcohol use disorder (AUD) remains a prevalent and challenging condition, with current behavioral and pharmaceutical treatments yielding limited success and high relapse rates. Non-invasive neuromodulation techniques, such as transcranial magnetic stimulation (TMS), offer promising therapeutic alternatives. TMS has demonstrated efficacy in modulating brain circuits associated with the limbic system and cognitive control, both critical in AUD pathology. While the dorsolateral prefrontal cortex (DLPFC) and medial prefrontal cortex (MPFC) have been identified as potential TMS targets, no studies have evaluated both sites against a sham condition in a single trial. This randomized, double-blind, sham-controlled clinical trial addresses this gap by evaluating the efficacy of multi-session intermittent theta burst stimulation (iTBS) applied to either the DLPFC or MPFC in reducing alcohol consumption, alcohol craving, and brain reactivity to alcohol cues. METHODS: One hundred and eighty individuals with AUD will be randomized to receive real iTBS to the MPFC, real iTBS to the DLPFC, or sham iTBS. Participants will complete 30 treatment sessions, administered in 15 daily sessions spread over 3 to 6 weeks, with pre- and post-treatment MRI scans and 3 months of follow-up. DISCUSSION: By evaluating two cortical targets and leveraging rigorous methodologies, this trial aims to generate insights that could inform future studies optimizing TMS for AUD treatment. Findings will contribute to developing standardized TMS protocols, with the potential to enhance treatment efficacy and support FDA approval, advancing TMS as an intervention for AUD. TRIAL REGISTRATION: ClinicalTrials.gov NCT04154111. Registered on November 6, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kinney KR, Kirse HA, Stewart NE, et al. Theta Burst Stimulation as a tool to decrease drinking in treatment-seeking alcohol users: study protocol for a randomized, double-blind, sham-controlled clinical trial. Trials. 2025. PMID: 41214823. doi:10.1186/s13063-025-09093-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。